Skip to main content
Clinical Trials/JPRN-UMIN000002660
JPRN-UMIN000002660
Completed
未知

A prospective study on prediction of sensitivity to trastuzumab using gene expression of peripheral blood mononuclear cells - A prospective study on prediction of sensitivity to trastuzumab using gene expression of peripheral blood mononuclear cells

Chikako Shimizu, Kenji Tamura0 sites60 target enrollmentOctober 22, 2009
Conditionsbresat cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
bresat cancer
Sponsor
Chikako Shimizu, Kenji Tamura
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2009
End Date
March 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chikako Shimizu, Kenji Tamura

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. uncontrolled CNS metastasis 2\. co\-existence of heart failure or past history of decline in cardiac function during trastuzumab treatment 3\. pregnant women

Outcomes

Primary Outcomes

Not specified

Similar Trials